Status:
WITHDRAWN
Autologous Stem Cell Therapy in Stroke
Lead Sponsor:
Neurogen Brain and Spine Institute
Conditions:
Stroke
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
Brief Summary
The purpose of this study was to study the safety and effect of stem cell therapy on the functional recovery in patients with sub acute/chronic stroke.
Eligibility Criteria
Inclusion
- Age18 years-80 years
- diagnosed as stroke by clinical and MRI findings
Exclusion
- presence of respiratory distress
- presence of acute infections such as Human Immunodeficient Virus/Hepatitis B Virus/ Hepatitis C Virus
- malignancies
- acute medical conditions such as respiratory infection, fever
- hemoglobin less than 8
- bleeding tendency
- bone marrow disorder
- left ventricular ejection fraction \< 30%
- pregnancy or breastfeeding
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02245698
Start Date
December 1 2008
End Date
December 1 2018
Last Update
October 25 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurogen brain and spine institute
Navi Mumbai, Maharashtra, India, 400706